A prospective analysis of microsatellite instability as a molecular marker in colorectal cancer.
Am J Surg
; 191(5): 646-51, 2006 May.
Article
in En
| MEDLINE
| ID: mdl-16647353
ABSTRACT
BACKGROUND:
Microsatellite instability (MSI) may be a molecular marker of colorectal tumor biology. We sought to evaluate the incidence and significance of MSI in an unselected colorectal cancer population.METHODS:
Colorectal cancer cases from a community health system were prospectively evaluated for MSI and patient outcomes monitored.RESULTS:
Of 240 eligible, 140 underwent testing; 43 (31%) had high-frequency MSI (MSI-H). Those with MSI-H tumors presented with earlier disease stage (P = .014) and lymphocytic infiltration (P < .001). Stage III MSI-H patients trended toward improved disease-free survival (P = .065). MSI-H patients were more likely to have other primary malignancies.CONCLUSIONS:
Prevalence of MSI-H in the general colorectal cancer population is higher than previously reported. MSI testing of colorectal cancers is useful as part of a molecular profile to stratify patients for prognosis, treatment, and further study. Patients with MSI-H tumors are more likely to have other primary malignancies, suggesting a role for heightened screening.
Search on Google
Database:
MEDLINE
Main subject:
RNA, Neoplasm
/
Colorectal Neoplasms
/
Biomarkers, Tumor
/
Microsatellite Repeats
/
Genomic Instability
Type of study:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
Country/Region as subject:
America do norte
Language:
En
Year:
2006
Type:
Article